NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors
Gao, X. ; Patnaik, A. ; Lakhani, N. J. ; Call, J. A. ; Galsky, M. D. ; Garmezy, B. ; Wei, A. Z. ; Carter, L. ; Powles, T. ; Siefker-Radtke, A. O. ... show 10 more
Gao, X.
Patnaik, A.
Lakhani, N. J.
Call, J. A.
Galsky, M. D.
Garmezy, B.
Wei, A. Z.
Carter, L.
Powles, T.
Siefker-Radtke, A. O.
Abstract
Description
Date
2025
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Gao X, Patnaik A, Lakhani NJ, Call JA, Galsky MD, Garmezy B, et al. NEXUS-01, a phase 1 study of LY4052031, an antibody-drug conjugate targeting Nectin-4 in participants with advanced or metastatic urothelial carcinoma or other solid tumors. JOURNAL OF CLINICAL ONCOLOGY. 2025 FEB 10;43(5_SUPPL):TPS900-TPS. PubMed PMID: WOS:001454666200012. English.